Objective: Vascular risk factors (VRFs) have been associated with stroke and cognitive impairment, however, the role of VRFs in predicting post-stroke depression (PSD) has not been assessed. The objective of the current study was to determine whether VRFs are associated with the risk of PSD in an acute stroke population. Methods: In this observational study, patients meeting World Health Organization MONICA Project and National Institute of Neurological Disorders and Stroke criteria for stroke were eligible. Patients were assessed for depression, cognition, and stroke severity, and VRF and demographic information were obtained. Results: A total of 102 patients were recruited within 4 months post-stroke. Using a score of ≥16 on the Center for Epidemiological Studies Depression scale to determine depressive symptoms, 38 patients (age 72.1 ± 15.6, 44.7% male) screened positive for depressive symptoms and 64 (age 70.1 ± 13.6, 51.6% male) screened negative. Analysis of VRFs showed that only hypertension (P = .044) independently predicted the presence of depressive symptoms (χ2 = 4.742, P = .029, Nagelkerke R2 = .062). Conclusions: Hypertension was associated with post-stroke depressive symptoms, while there was no relationship between PSD and other VRFs. Hypertension may have a greater impact than other VRFs on mood following stroke and may have a role in prevention and treatment of PSD.
Fact sheet: The top ten causes of death: World Health Organization; 2008.
2.
Heart Disease and Stroke Statistics–2009 Update (At-a-Glance Version). Dallas, TX: American Heart Association; 2009.
3.
HouseADennisMMogridgeLWarlowCHawtonKJonesL. Mood disorders in the year after first stroke. Br J Psychiatry. 1991; 158: 83–92.
4.
GottliebDSalagnikIKipnisMBrillS. Post stroke depression, first year post stroke, in middle band patients. Int J Geriatr Psychiatry. 2002; 17(5): 486–487.
5.
PohjasvaaraTLeppavuoriASiiraIVatajaRKasteMErkinjunttiT. Frequency and clinical determinants of poststroke depression. Stroke. 1998; 29(11): 2311–2317.
6.
HackettMLYapaCParagVAndersonCS. Frequency of depression after stroke: a systematic review of observational studies. Stroke. 2005; 36(6): 1330–1340.
AstromMAsplundKAstromT. Psychosocial function and life satisfaction after stroke. Stroke. 1992; 23(4): 527–531.
11.
FrancisPLHerrmannNTennenGLanctôtKL. A brief history of post-stroke depression neuroimaging. Aging Health. 2009; 5: 79–88.
12.
BhogalSKTeasellRFoleyNSpeechleyM. Lesion location and poststroke depression: systematic review of the methodological limitations in the literature. Stroke. 2004; 35(3): 794–780.
13.
CummingsJL. Frontal-subcortical circuits and human behavior. Arch Neurol. 1993; 50(8): 873–880.
RaisonCLCapuronLMillerAH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006; 27(1): 24–31.
16.
SpallettaGBossuPCiaramellaABriaPCaltagironeCRobinsonRG. The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines. Mol Psychiatry. 2006; 11(11): 984–991.
17.
FangJChengQ. Etiological mechanisms of post-stroke depression: a review. Neurol Res. 2009; 31(9): 904–909.
18.
HackettMLAndersonCS. Predictors of depression after stroke: a systematic review of observational studies. Stroke. 2005; 36(10): 2296–2301.
19.
SinghABlackSEHerrmannN. Functional and neuroanatomic correlations in poststroke depression: the Sunnybrook Stroke Study. Stroke. 2000; 31(3): 637–644.
20.
AströmMAdolfssonRAsplundK. Major depression in stroke patients. A 3-year longitudinal study. Stroke. 1993; 24(7): 976–982.
21.
OuimetMAPrimeauFColeMG. Psychosocial risk factors in poststroke depression: a systematic review. Can J Psychiatry. 2001; 46(9): 819–828.
22.
AbenIDenolletJLousbergRVerheyFWojciechowskiFHonigA. Personality and vulnerability to depression in stroke patients: a 1-Year prospective follow-up study. Stroke. 2002; 33(10): 2391–2395.
23.
HerrmannNBlackSELawrenceJSzekelyCSzalaiJP. The sunnybrook stroke study: a prospective study of depressive symptoms and functional outcome. Stroke. 1998; 29(3): 618–624.
24.
PoynterBShumanMDiaz-GranadosNKapralMGraceSLStewartDE. Sex differences in the prevalence of post-stroke depression: a systematic review. Psychosomatics. 2009; 50(6): 563–569.
25.
SteffensDCKrishnanKRCrumpCBurkeGL. Cerebrovascular disease and evolution of depressive symptoms in the cardiovascular health study. Stroke. 2002; 33(6): 1636–1644.
26.
AndersonRJFreedlandKEClouseRELustmanPJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001; 24(6): 1069–1078.
27.
FaithMSMatzPEJorgeMA. Obesity-depression associations in the population. J Psychosom Res. 2002; 53(4): 935–942.
28.
McElroySLKotwalRMalhotraSNelsonEBKeckPENemeroffCB. Are mood disorders and obesity related? A review for the mental health professional. J Clin Psychiatry. 2004; 65(5): 634–651.
29.
BreslauNPetersonELSchultzLRChilcoatHDAndreskiP. Major depression and stages of smoking. A longitudinal investigation. Arch Gen Psychiatry. 1998; 55(2): 161–166.
30.
DeschaintreYRichardFLeysDPasquierF. Treatment of vascular risk factors is associated with slower decline in Alzheimer disease. Neurology. 2009; 73(9): 674–680.
31.
WoodWGEliasMFSchultzNRPentzCA. Anxiety and depression in young and middle aged hypertensive and normotensive subjects. Exp Aging Res. 1979; 5(1): 15–30.
32.
Investigators. WMPP. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol. 1988; 41(2): 105–114.
33.
FoulkesMAWolfPAPriceTRMohrJPHierDB. The stroke data bank: design, methods, and baseline characteristics. Stroke. 1988; 19(5): 547–554.
34.
KunitzSCGrossCRHeymanA. The pilot stroke data bank: definition, design, and data. Stroke. 1984; 15(4): 740–746.
35.
WilliamsLSYilmazEYLopez-YunezAM. Retrospective assessment of initial stroke severity with the NIH stroke scale. Stroke. 2000; 31(4): 858–862.
36.
RadloffLS. The CES-D scale: a self-report depression scale for research in the general population. App Psychol Meas. 1977; 1: 385–401.
37.
FolsteinMFFolsteinSEMcHughPR. ‘’Mini-mental state.’’ A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3): 189–198.
38.
MolloyDWAlemayehuERobertsR. Reliability of a standardized mini-mental state examination compared with the traditional mini-mental state examination. Am J Psychiatry. 1991; 148(1): 102–105.
39.
BeekmanATDeegDJVan LimbeekJBraamAWDe VriesMZ.Van TilburgW. Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): results from a community-based sample of older subjects in The Netherlands. Psychol Med. 1997; 27(1): 231–235.
40.
ChatterjeeKFallSBarerD. Mood after stroke: a case control study of biochemical, neuro-imaging and socio-economic risk factors for major depression in stroke survivors. BMC Neurol. 2010; 10(125): 1–10.
41.
WaalHJ. Propranolol-induced depression. Br Med J. 1967; 2(5543): 50.
AvornJEverittDEWeissS. Increased antidepressant use in patients prescribed beta-blockers. JAMA. 1986; 255(3): 357–360.
44.
SimonsonWHanLFDavidsonHE. Hypertension treatment and outcomes in US nursing homes: results from the US National Nursing Home Survey. J Am Med Dir Assoc. 2011; 12(1): 44–49.
45.
KoDTHebertPRCoffeyCSSedrakyanACurtisJPKrumholzHM. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA. 2002; 288(3): 351–357.
46.
van MelleJPVerbeekDEvan den BergMPOrmelJvan der LindeMRde JongeP. Beta-blockers and depression after myocardial infarction: a multicenter prospective study. J Am Coll Cardiol. 2006; 48(11): 2209–2214.
47.
JonasBSFranksPIngramDD. Are symptoms of anxiety and depression risk factors for hypertension? Longitudinal evidence from the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Fam Med. 1997; 6(1): 43–49.
48.
DavidsonKJonasBSDixonKEMarkovitzJH. Do depression symptoms predict early hypertension incidence in young adults in the CARDIA study?Arch Intern Med. 2000; 160(10): 1495–1500.
49.
PattenSBWilliamsJVLavoratoDHCampbellNREliasziwMCampbellTS. Cerebrovascular disease and evolution of depressive symptoms in the cardiovascular health study stroke. Psychosom Med. 2009; 71(3): 273–279.
50.
MeyerCMArmenianHKEatonWWFordDE. Incident hypertension associated with depression in the Baltimore Epidemiologic Catchment area follow-up study. J Affect Disord. 2004; 83(2-3): 127–133.
51.
RubinRRCiechanowskiPEgedeLELinEHLustmanPJ. Recognizing and treating depression in patients with diabetes. Curr Diab Rep. 2004; 4(2): 119–125.
52.
CiechanowskiPSKatonWJRussoJE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000; 160(21): 3278–3285.
53.
LiebetrauMSteenBSkoogI. Depression as a risk factor for the incidence of first-ever stroke in 85-year-olds. Stroke. 2008; 39(7): 1960–1965.
54.
AxonRNZhaoYEgedeLE. Association of depressive symptoms with all-cause and ischemic heart disease mortality in adults with self-reported hypertension. Am J Hypertens. 2010; 23(1): 30–37.
55.
SimonsickEMWallaceRBBlazerDGBerkmanLF. Depressive symptomatology and hypertension-associated morbidity and mortality in older adults. Psychosom Med. 1995; 57(5): 427–435.
56.
HénonHPasquierFDurieuI. Preexisting dementia in stroke patients. Baseline frequency, associated factors, and outcome. Stroke. 1997; 28(12): 2429–2436.
57.
SkoogINilssonLPalmertzBAndreassonLASvanborgA. A population-based study of dementia in 85-year-olds. N Engl J Med. 1993; 328(3): 153–158.
58.
DufouilCde Kersaint-GillyABesanconV. Longitudinal study of blood pressure and white matter hyperintensities: the EVA-MRI cohort. Neurology. 2001; 56(7): 921–926.
59.
de LeeuwFEde GrootJCOudkerkM. Hypertension and cerebral white matter lesions in a prospective cohort study. Brain. 2002125(pt 4): 765–772.
60.
HowardGWagenknechtLECaiJCooperLKrautMATooleJF. Cigarette smoking and other risk factors for silent cerebral infarction in the general population. Stroke. 1998; 29(5): 913–917.
61.
de GrootJde LeeuwFEOudkerkMHofmanAJollesJBretelerMM. Cerebral white matter lesions and depressive symptoms in elderly adults. Arch Gen Psychiatry2000; 57(11): 1071–1076.
62.
AlexopoulosGSKellyRE Jr. Research advances in geriatric depression. World Psychiatry. 2009; 8(3): 140–149.
63.
VatajaRPohjasvaaraTLeppävuoriA. Magnetic resonance imaging correlates of depression after ischemic stroke. Arch Gen Psychiatry. 2001; 58(10): 925–931.
64.
BeersMHPassmanLJ. Antihypertensive medications and depression. Drugs. 1990; 40(6): 792–799.
